BOSTON SCIENTIFIC CORPORATION VALITUDE CRT-P; PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P)
|
Back to Search Results |
|
Model Number U125 |
Device Problems
Failure to Capture (1081); High impedance (1291); Over-Sensing (1438); High Capture Threshold (3266)
|
Patient Problems
Syncope (1610); Bradycardia (1751); Fall (1848); Head Injury (1879)
|
Event Date 10/08/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.Investigation of the available information determined this device exhibited oversensing of noise generated by the minute ventilation (mv)/respiratory sensor that is related to a high impedance condition.Please see the description for more information regarding the specific circumstances of this event.This device was included in the recent minute ventilation sensor signal oversensing advisory population.
|
|
Event Description
|
It was reported that this cardiac resynchronization therapy pacemaker (crt-p) patient presented to the emergency room after experiencing syncope causing the patient to fall and hit their head.The device was interrogated and found loss of capture on both other manufacturer right ventricular and left ventricular leads.There were observations of fluctuating high impedances and high thresholds causing the loss of capture.Due to the patient condition they did not try to reproduce any noise.The device was reprogrammed to unipolar pace/bipolar sense, and impedance and thresholds came back down.When checking yesterday, it appeared that the minute ventilation sensor was sensing the high impedances creating noise (not oversensed), however it was mitigated by turning the rate response trend feature off.Technical services discussed performing additional troubleshooting focused on clavicular region.The patient had hit their head when they fell and a ct scan was performed, however the patient was doing much better the following day.The device system remains in-service.No additional adverse patient effects were reported.
|
|
Search Alerts/Recalls
|
|
|